Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

NVS 83.51 +0.77 (0.93%)
price chart
Novartis AG (ADR) (NYSE:NVS): Reviewing Earnings Estimates
Novartis AG (ADR) (NYSE:NVS) soared 0.51% or +0.42 points during previous trade after opening at the price of $81.92, a total of 1.58M shares exchanged hands compared with its average trading volume of 1.71M shares.
Novartis AG (ADR) 2Q Earnings: Here's What To Expect?  Bidness ETC
Novartis AG (ADR) (NYSE:NVS) Biosimilars Roadmap
Novartis AG (ADR) (NYSE:NVS) is in the process of tripling its portfolio of biosimilar drugs by 2020. The company is particularly working to develop alternatives to blockbuster drugs such as Johnson & Johnson (NYSE:JNJ) Remicade and Amgen, Inc.
Novartis AG (ADR) Has Enough Arsenal to Steer Clear of Ongoing Rout  Bidness ETC
How Novartis AG (NYSE:NVS) trades after earning announcements?  Zergwatch
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Will Novartis AG (ADR) Go Down Anytime Soon?
The stock of Novartis AG (ADR) (NYSE:NVS) is a huge mover today! About 398,721 shares traded hands. Novartis AG (ADR) (NYSE:NVS) has declined 2.98% since December 15, 2015 and is downtrending. It has underperformed by 8.94% the S&P500.
Is Major Move Coming For Novartis AG (ADR) After This Gap Up?  Press Telegraph
How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.
Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...
Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...
Benzinga's Volume Movers  Benzinga
Novartis AG (ADR) (NYSE:NVS) Sells 14 Drug Brands Worth $293 Million To Sun In ...
Novartis AG (ADR) (NYSE:NVS) has sold more than a dozen drugs to India's Sun Pharmaceutical in Japan. The development follows a trend that has become popular among major pharmaceutical companies.
Hedge Funds Aren't Crazy About Novartis AG (ADR) (NVS) Anymore
We can judge whether Novartis AG (ADR) (NYSE:NVS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Novartis AG Enbrel Biosimilar Receives FDA Approval
The US Food and Drug Administration (FDA) Advisory Committee has approved Novartis AG's (ADR) (NYSE:NVS) GP2015, a biosimilar version of Enbrel.
Will Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) And Novartis AG (ADR ...
It is not clear whether Teva's Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Novartis AG (ADR)(NYSE:NVS) are trying to fend off copy cats.